文献速递膀胱癌与上尿路尿路上皮癌

接受根治性膀胱切除术女性的妇科器官受累:一项多中心研究

Gynaecological organ involvement in females undergoing radical cystectomy: a multicentre study.
PubMed 文献 · BJU Int · 2024-01-04

这项回顾性多中心研究分析了2009年1月至2022年3月三家高容量机构的1600例根治性膀胱切除术,其中302例女性膀胱癌患者中20例(6.6%)存在妇科器官恶性肿瘤受累。多变量分析显示cT4期是恶性妇科器官受累的独立预测因素(比值比88.3,95%CI 10.1-1214;P<0.001)。作者认为在无临床或影像学证据提示性器官受累时,结果不支持在根治性膀胱切除术时常规切除这些器官。

要点

  • 302例女性根治性膀胱切除标本中20例(6.6%)发现妇科器官恶性肿瘤受累。
  • 受累部位最常见为子宫(5例)和阴道壁(4例),其次为宫颈(1例)和卵巢(1例)。
  • cT4期是恶性妇科器官受累的独立预测因素(比值比88.3,95%CI 10.1-1214;P<0.001)。

核心结论

  • 作者报告了目前最大规模的多机构研究,评估接受根治性膀胱切除术的女性膀胱癌患者中恶性妇科器官受累情况。
  • 根治性膀胱切除术时妇科器官受累率低,且与较高的临床分期相关。
  • 在无临床或影像学证据提示性器官受累时,作者的结果不支持在根治性膀胱切除术时常规切除这些器官。

研究设计与样本

  • 回顾性多中心研究,纳入三家高容量机构2009年1月至2022年3月期间的1600例根治性膀胱切除术。
  • 回顾女性根治性膀胱切除标本中妇科器官的病理学发现。
  • 采用多变量逻辑回归分析识别根治性膀胱切除术时恶性妇科器官受累的预测因素。

主要发现

  • 共302例女性接受根治性膀胱切除术,中位(四分位距)年龄为68(61-75)岁,因临床(c)Ta-T4期膀胱癌手术。
  • 56例患者(18.5%)接受新辅助化疗。
  • 20例患者(6.6%)发现恶性妇科器官受累;最常见的单一受累部位为子宫(5例)和阴道壁(4例),其次为宫颈(1例)和卵巢(1例)。
  • 9例患者存在一个以上妇科器官受累。
  • 根治性膀胱切除术中未发现女性偶发原发性妇科恶性肿瘤。

临床怎么用

  • 在无临床或影像学证据提示性器官受累时,作者的结果不支持在根治性膀胱切除术时常规切除这些器官。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the incidence of malignancy in gynaecological organs removed during radical cystectomy (RC). PATIENTS AND METHODS: A retrospective multicentre study of 1600 RCs at three high-volume institutions between January 2009 and March 2022 was performed. Pathological findings in gynaecological organs in female RC specimens were reviewed. Multivariable logistic regression analyses were used to identify predictors of malignant gynaecological organ involvement (GOI) at time of RC. RESULTS: Overall, 302 females with a median (interquartile range) age of 68 (61-75) years underwent RC for clinical (c)Ta-T4 bladder cancer. In all, 56 patients (18.5%) received neoadjuvant chemotherapy. Malignant GOI was seen in 20 patients (6.6%); the most common single sites of GOI were the uterus (five patients) and vaginal wall (four), followed by cervix (one), and ovaries (one). Nine patients had involvement of more than one gynaecological organ. No females had a primary gynaecological malignancy detected incidentally at RC. Patients with GOI were more likely to have cT3/T4 stage (P < 0.001), preoperative hydronephrosis (P = 0.004), lymphovascular invasion (P = 0.002), and squamous cell carcinoma (P = 0.005) than those without GOI. On multivariable analysis, cT4 stage was an independent predictor of malignant GOI (odds ratio 88.3, 95% confidence interval 10.1-1214; P < 0.001). CONCLUSION: To our knowledge, we present the largest multi-institutional study examining malignant GOI in females with bladder cancer undergoing RC. The rate of GOI at the time of RC is low and associated with higher clinical stage. In the absence of clinical or radiological evidence of sexual organ involvement, our results do not support their routine removal at the time of RC.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Lobo N, Uthayanan L, Uribe-Lewis S, et al. Gynaecological organ involvement in females undergoing radical cystectomy: a multicentre study. BJU Int. 2024. PMID: 38105508. doi:10.1111/bju.16268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。